Scarica l'app Stockscreener
45.43
2.99%
1.32
Dopo l'orario di chiusura:
45.24
-0.19
-0.42%
Precedente Chiudi:
$44.11
Aprire:
$43.51
Volume 24 ore:
435.04K
Relative Volume:
0.41
Capitalizzazione di mercato:
$2.82B
Reddito:
-
Utile/perdita netta:
$-229.97M
Rapporto P/E:
-10.51
EPS:
-4.3234
Flusso di cassa netto:
$-136.51M
1 W Prestazione:
-1.54%
1M Prestazione:
+22.78%
6M Prestazione:
+136.06%
1 anno Prestazione:
+979.10%
Intervallo 1D:
$43.03
$45.85
Intervallo di 1 settimana:
$42.83
$47.84
Portata 52W:
$2.8101
$47.84
Kodiak Sciences Inc Stock (KOD) Company Profile
Nome
Kodiak Sciences Inc
Settore
Industria
Telefono
650-281-0850
Indirizzo
1250 PAGE MILL RD, PALO ALTO, CA
Compare KOD vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
KOD
Kodiak Sciences Inc
|
45.43 | 2.74B | 0 | -229.97M | -136.51M | -4.3234 |
VRTX
Vertex Pharmaceuticals Inc
|
430.14 | 108.36B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
731.77 | 78.05B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
775.03 | 48.74B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
302.11 | 41.16B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
298.16 | 33.17B | 5.36B | 287.73M | 924.18M | 2.5229 |
Kodiak Sciences Inc Stock (KOD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-11 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2025-10-24 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2025-09-25 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2025-09-22 | Iniziato | Jefferies | Buy |
| 2025-08-14 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2024-12-09 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-09-05 | Iniziato | H.C. Wainwright | Neutral |
| 2023-12-11 | Ripresa | Goldman | Sell |
| 2023-11-17 | Aggiornamento | CapitalOne | Equal Weight → Overweight |
| 2023-07-27 | Downgrade | UBS | Buy → Neutral |
| 2023-07-25 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| 2023-07-25 | Downgrade | JP Morgan | Neutral → Underweight |
| 2023-07-24 | Downgrade | CapitalOne | Overweight → Equal Weight |
| 2023-07-24 | Downgrade | Jefferies | Buy → Hold |
| 2022-11-15 | Iniziato | CapitalOne | Overweight |
| 2022-08-02 | Downgrade | Citigroup | Neutral → Sell |
| 2022-02-24 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-02-11 | Iniziato | Goldman | Buy |
| 2022-02-02 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2021-05-11 | Aggiornamento | ROTH Capital | Neutral → Buy |
| 2021-03-12 | Iniziato | Evercore ISI | Outperform |
| 2021-03-01 | Downgrade | Barclays | Equal Weight → Underweight |
| 2021-02-17 | Downgrade | ROTH Capital | Buy → Neutral |
| 2021-01-25 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2020-12-17 | Iniziato | Berenberg | Buy |
| 2020-12-16 | Iniziato | UBS | Buy |
| 2020-12-11 | Iniziato | Citigroup | Neutral |
| 2020-11-30 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-11-16 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-13 | Downgrade | Goldman | Buy → Neutral |
| 2020-03-31 | Iniziato | BMO Capital Markets | Outperform |
| 2020-03-03 | Iniziato | Goldman | Buy |
| 2020-02-18 | Downgrade | Barclays | Overweight → Equal Weight |
| 2020-02-06 | Iniziato | SunTrust | Buy |
| 2020-01-08 | Iniziato | ROTH Capital | Buy |
| 2020-01-03 | Iniziato | Jefferies | Buy |
| 2019-12-24 | Iniziato | JP Morgan | Overweight |
| 2019-10-15 | Reiterato | Chardan Capital Markets | Buy |
| 2019-02-20 | Iniziato | Chardan Capital Markets | Buy |
| 2018-10-29 | Iniziato | Barclays | Overweight |
| 2018-10-29 | Iniziato | BofA/Merrill | Buy |
| 2018-10-29 | Iniziato | Morgan Stanley | Overweight |
Mostra tutto
Kodiak Sciences Inc Borsa (KOD) Ultime notizie
Kodiak Sciences stock is surging Friday: What's driving the action? - MSN
Diabetic Retinopathy Pipeline Set for Transformational Breakthroughs by 2026 with 55+ Therapies expanding Clinical Innovation from Kodiak Sciences, Regenxbio, Adverum Biotechnologies | DelveInsight - Barchart
Diabetic Retinopathy Pipeline Set for Transformational - openPR.com
BlackRock (KOD) holds 3.27M shares, a 5.3% stake in Kodiak Sciences (KOD) - Stock Titan
Kodiak Q4 loss wider than expected, pipeline development in focus - MSN
US stocks: Kodiak Sciences shares soar 68% after eye drug succeeds in late-stage study - MSN
Kodiak climbs on late-stage trial win for diabetic retinopathy therapy - MSN
Kodiak Sciences Reports Positive Trial Results for Diabetic Retinopathy - HarianBasis.co
Kodiak Sciences Inc (KOD): What’s the Chance of Success for Zenkuda? - Insider Monkey
KOD Kodiak Sciences Inc reports narrow Q4 2025 EPS beat, shares drop 3.74 percent on weak investor sentiment.Viral Trade Signals - Xã Thanh Hà
[ARS] Kodiak Sciences Inc. SEC Filing - Stock Titan
Executive pay and 2026 director vote at Kodiak Sciences (NASDAQ: KOD) - Stock Titan
Is Kodiak Sciences (KOD) stock stronger than industry leaders (-1.28%) 2026-04-22Diversification - Cổng thông tin điện tử tỉnh Lào Cai
Kodiak Sciences Inc. (NASDAQ:KOD) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Why Kodiak Sciences Stock Is On The Move - TipRanks
Kodiak Sciences Inc stock hits 52-week high at $46.69 By Investing.com - Investing.com Australia
Kodiak Sciences (NASDAQ:KOD) Hits New 12-Month HighWhat's Next? - MarketBeat
Kodiak Sciences Inc stock hits 52-week high at $46.69 - Investing.com
Kodiak Sciences (KOD) reports Q4 EPS of ($1.05) - MSN
Kodiak Sciences (NASDAQ:KOD) Stock Price Up 9.8%What's Next? - MarketBeat
Kodiak Sciences KOD Stock Soars On Phase 3 Win - timothysykes.com
Russell 2000 Rips To Record High — Here Are The Top Small Cap Gainers - Benzinga
Kodiak Sciences (NASDAQ: KOD) CFO exercises options, now holds 211,930 shares - Stock Titan
Kodiak Sciences (NASDAQ:KOD) Signals Behind Surge Points To Momentum - Kalkine Media
Kodiak Sciences Inc. (NASDAQ:KOD) Short Interest Up 39.8% in March - MarketBeat
Kodiak Sciences (KOD) Stock: Downtrend Signals? (Loses Ground) 2026-04-15Overvalued Stocks - Cổng thông tin điện tử tỉnh Lào Cai
Kodiak Sciences Stock Price Drops 5.5% - National Today
Kodiak Sciences (NASDAQ:KOD) Stock Price Down 5.5%Should You Sell? - MarketBeat
Kodiak Sciences shares jump on encouraging Phase 3 trial results - MSN
Kodiak Sciences (KOD) climbs 75% on stellar clinical results - MSN
Kodiak Sciences stock hits 52-week high at $45.73 By Investing.com - Investing.com Australia
Kodiak Sciences Stock Soars to New 52-Week High - National Today
Kodiak Sciences (NASDAQ:KOD) Hits New 52-Week HighHere's What Happened - MarketBeat
Kodiak Sciences stock hits 52-week high at $45.73 - Investing.com
Breakouts Watch: Is Kodiak Sciences Inc stock a smart retirement pickWeekly Trend Report & Weekly High Return Forecasts - baoquankhu1.vn
KOD SEC FilingsKodiak Sciences Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Is Kodiak Sciences (KOD) Balancing Dilution Risk And Survival After Auditor's Going Concern Opinion? - Sahm
Kodiak Sciences (KOD) Reports Q4 EPS of ($1.05) - Insider Monkey
Kodiak Sciences (KOD) price target increased by 56.62% to 56.71 - MSN
New Highs: How does Kodiak Sciences Inc compare to its peers2026 Trends & High Win Rate Trade Tips - baoquankhu1.vn
Kodiak Sciences Inc Azioni (KOD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.29%
0.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):